Baidu
map

血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

儿童朗格罕细胞组织细胞增生症诊疗规范（2021年版）

2021-05-13 中华人民共和国国家卫生健康委员会 卫健委

朗格罕细胞组织细胞增生症

为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平，保障医疗质量与安全，按照《关于进一步扩大儿童血液病恶性肿瘤救治管理病种范围的通知》（国卫办医函〔2021〕107号）要求，我委组织国家儿童医学中心（北京

中文标题：

儿童朗格罕细胞组织细胞增生症诊疗规范（2021年版）

发布机构：

中华人民共和国国家卫生健康委员会

发布日期：

2021-05-13

简要介绍：

为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平，保障医疗质量与安全，按照《关于进一步扩大儿童血液病恶性肿瘤救治管理病种范围的通知》（国卫办医函〔2021〕107号）要求，我委组织国家儿童医学中心（北京儿童医院）开展了儿童血液病、恶性肿瘤相关12个病种的诊疗规范制修订工作，形成了相关病种诊疗规范（2021年版）。

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7b7d01c00209ae54, title=儿童朗格罕细胞组织细胞增生症诊疗规范（2021年版）, enTitle=, guiderFrom=卫健委, authorId=0, author=, summary=为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平，保障医疗质量与安全，按照《关于进一步扩大儿童血液病恶性肿瘤救治管理病种范围的通知》（国卫办医函〔2021〕107号）要求，我委组织国家儿童医学中心（北京, cover=, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu May 13 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #484848;">为进一步提高儿童血液病、恶性肿瘤诊疗规范化水平，保障医疗质量与安全，</span><span style="color: #484848;">按照</span><span style="color: #484848;">《关于进一步扩大儿童血液病恶性肿瘤救治管理病种范围的通知》（国卫办医函</span><span style="color: #484848;">〔</span><span style="color: #484848;">2021</span><span style="color: #484848;">〕</span><span style="color: #484848;">107号）要求，</span><span style="color: #484848;">我委</span><span style="color: #484848;">组织</span><span style="color: #484848;">国家儿童医学中心</span><span style="color: #484848;">（北京儿童医院）</span><span style="color: #484848;">开展了</span><span style="color: #484848;">儿童血液病、恶性肿瘤相关</span><span style="color: #484848;">12</span><span style="color: #484848;">个病种</span><span style="color: #484848;">的</span><span style="color: #484848;">诊疗规范制修订</span><span style="color: #484848;">工作</span><span style="color: #484848;"><span style="color: #484848; font-family: 仿宋_GB2312;">，形成了相关病种诊疗规范（</span><span style="color: #484848; font-family: 仿宋_GB2312;">20</span></span><span style="color: #484848;">21</span><span style="color: #484848;">年版）。</span></p>, tagList=[TagDto(tagId=112038, tagName=朗格罕细胞组织细胞增生症)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6771, appHits=215, showAppHits=0, pcHits=1184, showPcHits=6556, likes=2, shares=17, comments=18, approvalStatus=1, publishedTime=Thu May 13 19:30:15 CST 2021, publishedTimeString=2021-05-13, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Thu May 13 19:30:09 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Thu Jan 04 21:26:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1233708, encodeId=c12e1233e0817, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:10:24 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233707, encodeId=3c1e1233e0715, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:09:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210607, encodeId=cbd9121060e85, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7425472376, createdName=ms5000001760787845, createdTime=Tue Apr 12 17:50:50 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081974, encodeId=2cf510819e447, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53535607634, createdName=薇尔莉特, createdTime=Mon Dec 20 08:13:01 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074992, encodeId=012e10e49921e, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJJmBKrLvqOIYOgTmXQG4l1dH4xHxAJm9ZgJeUcnufnSQ91HwQycuK0lFDypNay2cLj3IwgeZhaJQ/132, createdBy=a5e81535919, createdName=xueling0617, createdTime=Mon Nov 29 09:59:25 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2022-07-20 ms5000001683434619

    赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1233708, encodeId=c12e1233e0817, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:10:24 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233707, encodeId=3c1e1233e0715, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:09:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210607, encodeId=cbd9121060e85, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7425472376, createdName=ms5000001760787845, createdTime=Tue Apr 12 17:50:50 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081974, encodeId=2cf510819e447, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53535607634, createdName=薇尔莉特, createdTime=Mon Dec 20 08:13:01 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074992, encodeId=012e10e49921e, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJJmBKrLvqOIYOgTmXQG4l1dH4xHxAJm9ZgJeUcnufnSQ91HwQycuK0lFDypNay2cLj3IwgeZhaJQ/132, createdBy=a5e81535919, createdName=xueling0617, createdTime=Mon Nov 29 09:59:25 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2022-07-20 ms5000001683434619

    保存

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1233708, encodeId=c12e1233e0817, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:10:24 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233707, encodeId=3c1e1233e0715, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:09:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210607, encodeId=cbd9121060e85, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7425472376, createdName=ms5000001760787845, createdTime=Tue Apr 12 17:50:50 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081974, encodeId=2cf510819e447, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53535607634, createdName=薇尔莉特, createdTime=Mon Dec 20 08:13:01 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074992, encodeId=012e10e49921e, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJJmBKrLvqOIYOgTmXQG4l1dH4xHxAJm9ZgJeUcnufnSQ91HwQycuK0lFDypNay2cLj3IwgeZhaJQ/132, createdBy=a5e81535919, createdName=xueling0617, createdTime=Mon Nov 29 09:59:25 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2022-04-12 ms5000001760787845

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1233708, encodeId=c12e1233e0817, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:10:24 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233707, encodeId=3c1e1233e0715, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:09:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210607, encodeId=cbd9121060e85, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7425472376, createdName=ms5000001760787845, createdTime=Tue Apr 12 17:50:50 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081974, encodeId=2cf510819e447, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53535607634, createdName=薇尔莉特, createdTime=Mon Dec 20 08:13:01 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074992, encodeId=012e10e49921e, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJJmBKrLvqOIYOgTmXQG4l1dH4xHxAJm9ZgJeUcnufnSQ91HwQycuK0lFDypNay2cLj3IwgeZhaJQ/132, createdBy=a5e81535919, createdName=xueling0617, createdTime=Mon Nov 29 09:59:25 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-12-20 薇尔莉特

    保存

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1233708, encodeId=c12e1233e0817, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:10:24 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233707, encodeId=3c1e1233e0715, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Wed Jul 20 22:09:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210607, encodeId=cbd9121060e85, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7425472376, createdName=ms5000001760787845, createdTime=Tue Apr 12 17:50:50 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081974, encodeId=2cf510819e447, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53535607634, createdName=薇尔莉特, createdTime=Mon Dec 20 08:13:01 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074992, encodeId=012e10e49921e, content=保存, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJJmBKrLvqOIYOgTmXQG4l1dH4xHxAJm9ZgJeUcnufnSQ91HwQycuK0lFDypNay2cLj3IwgeZhaJQ/132, createdBy=a5e81535919, createdName=xueling0617, createdTime=Mon Nov 29 09:59:25 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-11-29 xueling0617

    保存

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map